GoodRx Holdings, Inc.
Close on Oct 19, 2026
- Market cap
- $1.17B
- P/E (TTM)
- 84.3
- Dividend yield
- –
About GoodRx
Services-Computer Processing & Data Preparation, SIC 7374
GoodRx Holdings, Inc. operates a digital healthcare platform that provides consumers with access to discounted prescription medication pricing. The company's primary offerings include prescription transaction services, which deliver digital discount codes for medication purchases outside of standard insurance networks. It also provides healthcare subscription services, such as GoodRx Gold, condition-specific programs, and RxSmartSaver+, alongside a telehealth service and pharmaceutical manufacturer solutions known as Pharma Direct. The company serves individual consumers purchasing prescription drugs and healthcare services, while also collaborating with healthcare providers, retail pharmacies, and pharmaceutical manufacturers.
The company conducts its operations within the United States, connecting consumers with retail partner pharmacies across the country's prescription medication market. GoodRx Holdings, Inc. maintains its principal executive offices and corporate headquarters in Santa Monica, California.
Summary of the business section of GoodRx's latest annual report, written by StockData.
Company profile
Company
- Legal name
- GoodRx Holdings, Inc.
- Headquarters
- Santa Monica, CA
- Address
- 2701 Olympic Boulevard 90404
- Phone
- (855) 268-2822
- Website
- goodrx.com
- Employees
- 697, Dec 31, 2025
- Industry
- Services-Computer Processing & Data Preparation
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- PricewaterhouseCoopers LLP, Los Angeles, California
Stock & identifiers
- Ticker
- GDRX
- Exchange
- Nasdaq
- IPO date
- Sep 24, 2020
- Shares outstanding
- 341M, Jul 28, 2026
- Public float
- $423.20M, Jun 30, 2025
- Filer category
- Accelerated filer
- SEC CIK
- 1809519
- CUSIP
- 38246G108
- ISIN
- US38246G1085
- LEI
- 529900ATKYECI45EHV09
- EIN
- 47-5104396
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Wendy Lynn Barnes | See Remarks, Director | 701,129 |
| Thomas (TC) Chan | Chief Accounting Officer | 15,647 |
| Justin Fengler | See Remarks | 52,087 |
| Christopher A. McGinnis | See Remarks | 214,604 |
| Romin Nabiey | Chief Accounting Officer | 185,949 |
| Karsten Voermann | Chief Financial Officer | 392,596 |
| Douglas Joseph Hirsch | Director | 5,712,929 |
| Kelly J. Kennedy | Director | 207,645 |
| Scott Wagner | Director | 472,997 |
| Trevor Bezdek | Director | 5,609,251 |
| Agnes Rey-Giraud | Director | 652,786 |
| Ronald E. Bruehlman | Director | 207,352 |
| Ian T. Clark | Director | 100,150 |
| Idea Men, LLC | Director | 43,164,171 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Barnes | $23.37M | $14.16M | $2.41M | $5 | $101 |
| FY2025 Bezdek | $0 | $0 | $2.41M | $5 | $101 |
| FY2025 Hirsch | $0 | $0 | $2.41M | $5 | $101 |
| FY2024 Bezdek | $0 | $0 | $2.63M | $9 | $98 |
| FY2024 Hirsch | $0 | $0 | $2.63M | $9 | $98 |
| FY2024 Wagner | $9.77M | $9.63M | $2.63M | $9 | $98 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025 , we employed 697 employees, all of which are full-time employees .”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Mar 18, 2026 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Jun 6, 2023 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Apr 15, 2022 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Sep 24, 2020 | IPO | Initial public offering priced (424B4 prospectus) |
| Sep 23, 2020 | Listing | Registration of securities on an exchange (Form 8-A) |